5250 Leetsdale Dr., Suite 208
Denver, CO 80246
Main (303) 371-9432
Corporate (405) 602-3927
Fax (303) 371-9521
After Hours 1 (866) 863-6114
The Lynn Institute of Denver opened in 2010 and represents Lynn Health Science Institute’s most recent expansion site. Located in Glendale, in the heart of Denver, the site offers easy access to patients. The site is open Monday – Friday.
The site general recruits for a variety of studies, such as: Diabetes, IBS, Contraception, Pain Studies, Obesity, Pulmonary Diseases, Arthritis and Flu Treatments.
Principal Investigator: Dr. Paramjit Parmar, MD
Dr. Parmar has been a board certified family practice physician since 2008.
He has worked with the Lynn Institute as an investigator for clinical trials since early 2012.
Manager/Study Coordinator: Kelly Radin, CCRC
Kelly has worked in clinical trials since 1993 and she has been with the Lynn Institute since 2005.
Study Coordinator: Christina Gallegos, MA
Christina has worked in clinical trials since 1991 and she has been with the Lynn Institute since 2012.
For more information or to participate in a clinical trial contact us at (303) 371-9432 or fill out our participant information form.
We are currently seeking participants with the following medical conditions:
We are currently seeking patients at least 12 years of age, diagnosed with persistent asthma, and frequently need to use an inhaler. Qualified participants may be compensated for time and travel.
If you are a female between the ages of 18 and 45, have a history of Bacterial Vaginosis, and are currently experiencing an episode of BV you may qualify for a medical research study. Qualified participants may be compensated for time and travel.
Have you been diagnosed with functional constipation? We are currently seeking patients who have been diagnosed for at least 3 months and have been experiencing symptoms for at least 6 months. Qualified participants may be compensated
Do you have a history of heart disease or are at high risk? We are currently seeking patients for two studies who are at high risk for cardiovascular disease and taking a statin or other lipid lowering treatment. Qualified participants may be compensated.
Type II Diabetes
You may qualify for the study if you have type 2 diabetes, AND you are age 30 or older and have had a heart attack or stroke, OR you are age 50 or older and have been told by your doctor that you are at high risk for heart disease.
Please call Christina for more information.